US-Printed Pharmaceutical Cartons: What Crosses the Border

What actually crosses the border with US-printed pharmaceutical cartons and inserts?

A US order may cross the border as pharmaceutical cartons, printed leaflets, pressure-sensitive labels and corrugated shipping cases, but each component can have a different customs treatment. Paperboard cartons and printed leaflets are not currently on the surtax list, while US-origin corrugated shipping cases are listed at 50%.

That distinction matters because a purchase order described simply as “cartons and inserts” can arrive as several physical products:

• Pharmaceutical cartons packed flat
• A folded or flat package insert
• Pressure-sensitive labels
• Corrugated master shipping cases
• Pallets, wrapping and other transport materials
• Samples, overruns or replacement components

The packaging supplier’s location does not settle the customs question. Classification, country of origin and the exact contents of the shipment all matter. Cross-border documentation should describe separately classifiable components rather than treating the order as one undifferentiated packaging product.

Which pharmaceutical packaging products are subject to the surtax?

Pharmaceutical cartons under 4819.20 and printed leaflets are not on the surtax list. Corrugated shipping cases under 4819.10.00 are subject to a 50% surtax when they are US-origin goods.

As of October 2026, Canada charges a surtax of 15%, 25% or 50% of the value for duty on listed goods that originate in the United States. The measure has applied since September 8, 2026, under the United States Surtax Order (2026).

For this product category, the practical result is:

Imported component	Current surtax position
Paperboard cartons, 4819.20	Not on the surtax list
Printed leaflets or package inserts	Not on the surtax list
Corrugated shipping cases, 4819.10.00	50% when US-origin
Pressure-sensitive labels	Confirm classification and origin with a customs broker

A shipment can therefore contain untaxed pharmaceutical cartons inside corrugated cases that are subject to the 50% surtax. Buyers should ask vendors to identify components separately rather than provide one vague description for the entire shipment.

Whether the surtax applies depends on tariff classification and country of origin under the CUSMA marking rules, not simply on where the seller has an office. It can also apply to US-origin goods shipped from another country, according to CBSA Customs Notice 26-23.

Companies acting as the importer of record should have a customs broker confirm classifications and origin treatment before placing the order. This is especially important when cartons, package inserts, labels and corrugated cases appear on the same invoice. Documents prepared for US customs or export reporting do not replace the information required for Canadian clearance.

What costs remain when cartons and inserts are not on the surtax list?

An order from a US vendor remains a commercial import even when the pharmaceutical cartons and printed inserts are not subject to the surtax. It still requires a Canadian customs entry, may generate brokerage or clearance charges, is usually priced in US dollars and can be held at the border.

The landed-cost calculation should include:

• The vendor’s quoted price
• Currency conversion and exchange-rate movement
• Freight to the Canadian destination
• Brokerage or customs-clearance charges
• GST collected at import
• Possible storage or administrative charges if clearance is delayed
• Internal time spent resolving paperwork or classification questions
• Replacement freight if part of the order is damaged, short or incorrect

These costs vary by job, shipment value, carrier arrangements and importer setup. For a useful comparison, the US quote should be converted into Canadian dollars and assessed against a Canadian quote with equivalent carton construction, insert format, finishing, quality controls and delivery terms. Published pharmaceutical packaging & labels pricing can help establish which specifications must be held constant during that comparison.

A small unit-price saving can disappear without any surtax being charged. Currency movement, one clearance invoice and staff time spent locating a delayed cross-border shipment may be enough to change the result.

How do the surtax and GST interact on listed goods?

GST is calculated on the value plus the surtax, not just on the original value for duty. That produces a second cost increase when a listed, US-origin component enters Canada.

In the government’s example, a $150 item subject to a 25% surtax incurs $37.50 in surtax. GST is then calculated on $187.50, bringing the combined surtax and GST to $46.88.

At the 50% level, the same $150 item incurs $75 in surtax and $11.25 in GST. The combined amount is $86.25.

These figures should not be applied to pharmaceutical cartons or printed leaflets because those products are not on the list. They illustrate the arithmetic relevant to listed goods, including US-origin corrugated shipping cases at 50%.

This detail is easy to miss when a vendor quotes the printed cartons but packs them in separately classifiable corrugated cases. The outer cases may look like a minor shipping detail until their origin and value have to be declared.

Which carton and insert specifications should buyers compare?

A reliable comparison starts with matching physical specifications, print requirements and packing instructions. Comparing unlike products creates apparent savings that rarely survive production or regulatory review.

Folding carton specifications

The carton request should identify:

• Finished dimensions and dieline version
• Board grade, caliper and colour
• Grain direction where structurally important
• Printing process and colour requirements
• Varnish, aqueous coating or other surface treatment
• Foil, embossing or debossing
• Die-cut windows, perforations and tear features
• Glue location and carton style
• Variable codes or version identifiers
• Packing orientation, bundle quantity and case requirements

Pharmaceutical cartons may need to remain readable through filling, packing, warehousing and retail distribution. Coatings and decorative finishes should therefore be evaluated alongside barcode performance, code adhesion, fold strength and scuff resistance.

If the carton forms part of a tamper-evident packaging system, the quote should also identify the relevant structural feature, seal or companion component. A printed statement alone does not make a package tamper-evident. The complete packaging configuration must support the intended function and applicable regulatory compliance requirements.

Insert and leaflet specifications

For a printed package insert, define:

• Flat and folded dimensions
• Page or panel count
• Paper stock and opacity
• Number of ink colours
• Folding pattern and final fold tolerance
• Grain direction
• Version or language identification
• Packing quantity and orientation
• Whether the insert is placed into the carton or supplied separately

Small changes in fold pattern can affect insertion equipment and carton fit. A leaflet that is technically the correct size but springs open, feeds inconsistently or arrives in the wrong orientation can slow packaging operations.

Accent Impression coordinates pharmaceutical cartons, labels and inserts for Canadian programs, including the print, finishing and kitting specifications required for distribution.

What Canadian-market artwork requirements should be planned?

Cartons, labels and inserts intended for the Canadian market need artwork that accommodates Canadian bilingual and regulatory requirements. Buyers should confirm approved English and French content, hierarchy, legibility and version control before releasing files.

That review should cover more than translation. It should also confirm:

• Which content appears on the carton, label and insert
• Whether both languages fit without reducing critical text excessively
• Panel sequence and reading order
• Product names, strengths and dosage formats
• Lot, expiry and variable-data areas
• Barcode placement and quiet zones
• Approved symbols and warnings
• Artwork revision numbers
• Market-specific legal review
• Tamper-evident statements where applicable
• Serialization or traceability fields required by the program

A US vendor may be fully capable of printing bilingual pharmaceutical cartons, but responsibility for supplying approved Canadian-market artwork still has to be assigned. The border does not correct a missing French panel, an outdated insert or a mismatched component version.

FDA requirements should not be treated as a substitute for Canadian review. FDA-regulated artwork may be relevant when the same product or packaging system is also intended for US distribution, but Canadian packaging must meet the requirements applicable in Canada. Differences can affect prescribing information, warnings, package insert content and other labeling elements.

A coordinated pharmaceutical packaging & labels specification is particularly useful when cartons, labels and inserts must carry the same revision, product code and market designation.

How do FDA, serialization and tamper-evident requirements affect a cross-border order?

FDA requirements primarily concern products intended for the US market. They can still affect a Canadian buyer when one production program serves both countries or when a US supplier uses FDA-oriented templates, quality procedures or artwork terminology.

Buyers should establish which market each component is approved for. An FDA-compliant US version should not be assumed to satisfy Canadian regulatory compliance requirements, and a Canadian bilingual version should not automatically be released for US distribution.

The same distinction applies to serialization. US pharmaceutical distribution may involve FDA-related rules and Drug Supply Chain Security Act processes that do not map directly onto every Canadian packaging program. If serialized data, barcodes or unique identifiers are required, the quote and artwork record should identify the market, data owner, code format, verification process and handling of rejected codes.

Tamper-evident requirements also depend on the product and packaging configuration. Where they apply, buyers should compare the complete system, including seals, closures, perforations or other evidence features, rather than comparing the printed carton alone.

When does importing create the most operational risk?

Cross-border sourcing becomes more consequential when packaging is time-sensitive, version-controlled or needed to keep a filling and packing schedule running. The risk is not limited to the customs amount shown on an invoice.

Common pressure points include:

• Launch quantities tied to a fixed production window
• Regulatory or artwork changes that make old inventory unusable
• Multiple strengths or SKUs with similar graphics
• Bilingual versions that must remain correctly paired
• Inserts that must match a specific carton revision
• Serialized components that require controlled data
• Replenishment orders required before existing stock runs out
• Retail or pharmacy distribution programs with scheduled allocation

A border hold does not need to last long to disrupt a packaging sequence. If the carton arrives but the revised insert does not, the finished pack may still be unable to proceed.

The rules have also changed several times since early 2025, and the order can be amended again. A purchase from a company in Canada does not depend on those border rules, customs entries or future changes to the surtax list.

How should buyers compare a US quote with a Canadian quote?

Compare the total landed and operational cost, not the printed unit price alone. The soundest buying decision accounts for specifications, currency, customs administration, corrugated cases, regulatory compliance and the cost of recovering from an error.

A practical quote comparison should use these columns:

Cost or risk	US order	Canadian order
Product price in CAD	Convert at a realistic rate	Use quoted amount
Carton surtax	Not currently listed	Not applicable as a border calculation
Printed-insert surtax	Not currently listed	Not applicable as a border calculation
US-origin corrugated-case surtax	50%	Confirm quote structure
GST treatment	Payable according to import treatment	Confirm quote terms
Brokerage or clearance	Usually billed to receiver	No Canadian customs entry for a domestic order
Border-delay exposure	Present	Not dependent on border clearance
Artwork and version coordination	Confirm responsibility	Confirm responsibility
FDA or Canadian market version	Identify the intended market	Identify the intended market
Replacement logistics	Include potential cross-border handling	Confirm replacement terms

The less dramatic items are often the ones that decide the purchase. A slightly lower printed price can be offset by exchange rates, clearance fees, case treatment and the administrative cost of sorting out a discrepancy.

Buyers developing their comparison criteria can consult more pharmaceutical packaging & labels guides for related questions about formats, artwork and production planning.

Frequently asked questions

Pharmaceutical cartons and printed inserts are not currently subject to the US-origin surtax, but sourcing them from the United States still creates customs, currency and logistics considerations. Corrugated shipping cases require separate attention because US-origin cases are listed at 50%.

Are US-printed pharmaceutical folding cartons subject to the surtax?

No. Pharmaceutical folding cartons under 4819.20 are not on the surtax list as of October 2026. They remain commercial goods entering Canada and still require customs entry.

Are printed pharmaceutical inserts subject to the surtax?

No. A printed leaflet or package insert is not on the current surtax list. Buyers should still account for brokerage or clearance, GST treatment, currency conversion and possible border delays.

Why do corrugated shipping cases need to appear separately on the quote?

US-origin corrugated shipping cases under 4819.10.00 are subject to a 50% surtax. Separating their description and value helps the importer and customs broker assess the shipment correctly.

Does buying from a US seller automatically mean the surtax applies?

No. Application depends on the product’s classification and country of origin under the CUSMA marking rules, not simply the seller’s location.

Can bilingual cartons and inserts be printed in the United States?

Yes, provided the approved artwork meets the Canadian market’s bilingual requirements. Buyers should establish responsibility for translation approval, legal review, version control and component matching.

Does FDA approval make packaging acceptable for Canada?

Not automatically. FDA requirements apply to the US market, while Canadian pharmaceutical packaging must meet the Canadian requirements applicable to the product. A shared packaging program should clearly separate US and Canadian artwork, insert content and approval records.

What should be confirmed before placing the order?

Confirm the carton and insert specifications, tariff classifications, origin of listed components, corrugated-case details, currency, shipping terms, brokerage responsibility, bilingual artwork approval and replacement process. Where applicable, also confirm serialization, tamper-evident features and market-specific regulatory review. A customs broker should verify classification and origin treatment.

Request a quote

Rather leave the border out of it? Our Montreal team quotes in Canadian dollars, on one Canadian invoice.

Request a quote